
Sign up to save your podcasts
Or


Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC.
LINK TO FULL TRANSCRIPT
By American Society of Clinical Oncology (ASCO)4.6
5656 ratings
Dr. Monty Pal shares highlights from the final day of ASCO26, including new research on treating anemia in myelofibrosis, advances in RAS-mutated mCRC, novel therapies for AML, and a potentially practice-changing trial in TNBC.
LINK TO FULL TRANSCRIPT

317 Listeners

506 Listeners

40 Listeners

67 Listeners

769 Listeners

121 Listeners

2,239 Listeners

822 Listeners

187 Listeners

46 Listeners

31 Listeners

847 Listeners

59 Listeners

196 Listeners

47 Listeners